Quality of Life in Patients With Alcohol Use Disorder
QUALIFACT
Factors Associated With Quality of Life in Patients With Alcohol Use Disorder
1 other identifier
interventional
167
1 country
1
Brief Summary
The primary purpose of this study is to investigate the factors associated with quality of life of patients with alcohol use disorder (AUD) undergoing a detoxification program (cross-sectional analysis). The secondary purpose is (1) to identify the factors associated with change in quality of life between baseline and 6-month follow-up, and (2) to identify the factors associated with alcohol relapse at 6 months (longitudinal analyses).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2021
CompletedFirst Posted
Study publicly available on registry
February 10, 2021
CompletedStudy Start
First participant enrolled
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2025
CompletedJuly 31, 2025
July 1, 2025
3.4 years
January 19, 2021
July 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of life in patients with AUD.
Alcohol Quality of Life Scale.
Within the 10th and 21st day of the detoxification program (baseline assessment).
Secondary Outcomes (2)
Quality of life in patients with AUD 6 months after the detoxification program.
6 months after the baseline assessment.
Alcohol status
6 months after the baseline assessment.
Study Arms (1)
Quality of life of patients with AUD.
OTHERPatients' demographic data, socioeconomic status, physical diseases, medication use, clinical features of AUD, psychiatric variables, impulsivity, autonomy, sexual functioning, sleep quality, and cognitive functioning will be measured at baseline. The Alcohol Quality of Life Scale (AQoLS) will be completed at baseline and at 6-month follow-up. Alcohol status (relapse/abstinence) will be assessed at 6 months.
Interventions
The Alcohol Quality of Life Scale (AQoLS) will be completed at baseline and at 6-month follow-up. Alcohol status (relapse/abstinence) will be assessed at 6 months.
Eligibility Criteria
You may qualify if:
- DSM-5 AUD criteria
- At least 18 years of age
- Within the 10th and 21st day of a detoxification program.
You may not qualify if:
- Communication difficulties (insufficient level of French, major hearing or visual impairment, major cognitive deficit)
- Under guardianship
- Under justice control
- Cannot be reached by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, 69678 cedex, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin ROLLAND, MD, PhD
CH LE VINATIER
- STUDY DIRECTOR
LOUIS FERDINAND LESPINE, MD
CH LE VINATIER
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2021
First Posted
February 10, 2021
Study Start
March 25, 2021
Primary Completion
August 8, 2024
Study Completion
January 21, 2025
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share